Kidney Complications of Hematopoietic Stem Cell Transplantation

被引:40
作者
Singh, Neeraj [1 ]
McNeely, Jonathan [1 ]
Parikh, Samir [1 ]
Bhinder, Arvinder [2 ]
Rovin, Brad H. [1 ]
Shidham, Ganesh [1 ]
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Div Nephrol, Dept Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Div Med Oncol, Dept Internal Med, Columbus, OH 43210 USA
关键词
Hematopoietic stem cell transplantation; transplant-associated thrombotic microangiopathy; acute kidney injury; chronic kidney disease; BONE-MARROW-TRANSPLANTATION; HEMOLYTIC-UREMIC SYNDROME; TOTAL-BODY IRRADIATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VERSUS-HOST-DISEASE; HEPATIC VENOOCCLUSIVE DISEASE; VON-WILLEBRAND-FACTOR; TUMOR LYSIS SYNDROME; ACUTE-RENAL-FAILURE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS;
D O I
10.1053/j.ajkd.2012.09.020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hematopoietic stem cell transplantation (HSCT) exposes a patient's kidneys to a unique combination of challenges, including high-dose radiation, anemia, chemotherapeutic agents, graft-versus-host disease, opportunistic infections, attenuated and altered immunologic responses, fluid and electrolyte imbalances, and extensive courses of antimicrobial agents. Since the inception of HSCT in the 1950s, there has been increasing interest in defining, determining, and managing the kidney complications that accompany this procedure. In this article, we review the common causes of acute kidney injury and chronic kidney disease that occur with HSCT, including HSCT-associated thrombotic microangiopathy, a distinct cause of chronic kidney disease with a multifactorial cause previously known as bone marrow transplant nephropathy or radiation nephropathy. Additionally, we review other kidney complications, including calcineurin inhibitor nephrotoxicity and chronic graft-versus-host disease-associated glomerulonephritis, that develop post-HSCT. Critically, due to its grave prognosis, it is important to identify HSCT-associated thrombotic microangiopathy early, as well as distinguish it from the other causes of chronic kidney disease. Am J Kidney Dis. 61(5): 809-821. (C) 2013 by the National Kidney Foundation, Inc.
引用
收藏
页码:809 / 821
页数:13
相关论文
共 174 条
[1]   DELAYED RENAL-FAILURE WITH EXTENSIVE MESANGIOLYSIS FOLLOWING BONE-MARROW TRANSPLANTATION [J].
ANTIGNAC, C ;
GUBLER, MC ;
LEVERGER, G ;
BROYER, M ;
HABIB, R ;
LACOSTE, M ;
BEZIAU, A ;
NAIZOT, C .
KIDNEY INTERNATIONAL, 1989, 35 (06) :1336-1344
[2]  
Arai S, 2001, Hematol J, V2, P292, DOI 10.1038/sj.thj.6200127
[3]   IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN [J].
ASADA, Y ;
SUMIYOSHI, A ;
HAYASHI, T ;
SUZUMIYA, J ;
KAKETANI, K .
THROMBOSIS RESEARCH, 1985, 38 (05) :469-479
[4]   Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab [J].
Au, Wing-Yan ;
Ma, Edmond S. ;
Lee, Tsz-Leung ;
Ha, Shau-Yin ;
Fung, Alvin T. ;
Lie, Albert K. W. ;
Kwong, Yok-Lam .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) :475-478
[5]   Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor [J].
Balduini, CL ;
Frassoni, F ;
Noris, P ;
Klersy, C ;
Iannone, AM ;
Bacigalupo, A ;
Giorgiani, G ;
Di Pumpo, M ;
Locatelli, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) :951-953
[6]   Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? [J].
Batts, E. D. ;
Lazarus, H. M. .
BONE MARROW TRANSPLANTATION, 2007, 40 (08) :709-719
[7]   A PHASE-I PHASE-II STUDY OF PROSTAGLANDIN-E1 FOR THE PREVENTION OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BONE-MARROW TRANSPLANTATION [J].
BEARMAN, SI ;
SHEN, DD ;
HINDS, MS ;
HILL, HA ;
MCDONALD, GB .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (04) :724-730
[8]   RADIATION NEPHRITIS FOLLOWING TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IN PREPARATION FOR BONE-MARROW TRANSPLANTATION [J].
BERGSTEIN, J ;
ANDREOLI, SP ;
PROVISOR, AJ ;
YUM, M .
TRANSPLANTATION, 1986, 41 (01) :63-66
[9]   Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].
Bianchi, V ;
Robles, R ;
Alberio, L ;
Furlan, M ;
Lämmle, B .
BLOOD, 2002, 100 (02) :710-713
[10]   Renal toxicity after total body irradiation [J].
Borg, M ;
Hughes, T ;
Horvath, N ;
Rice, M ;
Thomas, AC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04) :1165-1173